Oligodeoxyribonucleotides, Antisense
"Oligodeoxyribonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
MeSH Number(s)
D13.150.200.640
D13.150.480.640
D13.444.308.150.640
D13.444.600.150.200.640
D13.444.600.150.640.640
D13.695.578.424.480.640
D27.720.470.530.600.150.200.640
D27.720.470.530.600.150.640.640
Concept/Terms
Oligodeoxyribonucleotides, Antisense- Oligodeoxyribonucleotides, Antisense
- Antisense Oligodeoxyribonucleotides
- Antisense OligoDNA
- OligoDNA, Antisense
- Anti-Sense Oligodeoxyribonucleotides
- Anti Sense Oligodeoxyribonucleotides
- Oligodeoxyribonucleotides, Anti-Sense
- Oligodeoxyribonucleotide, Antisense
- Antisense Oligodeoxyribonucleotide
Below are MeSH descriptors whose meaning is more general than "Oligodeoxyribonucleotides, Antisense".
- Chemicals and Drugs [D]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Antisense Elements (Genetics) [D13.150]
- DNA, Antisense [D13.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.150.200.640]
- Oligonucleotides, Antisense [D13.150.480]
- Oligodeoxyribonucleotides, Antisense [D13.150.480.640]
- Nucleic Acids [D13.444]
- DNA [D13.444.308]
- DNA, Antisense [D13.444.308.150]
- Oligodeoxyribonucleotides, Antisense [D13.444.308.150.640]
- Nucleic Acid Probes [D13.444.600]
- Antisense Elements (Genetics) [D13.444.600.150]
- DNA, Antisense [D13.444.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.200.640]
- Oligonucleotides, Antisense [D13.444.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.640.640]
- Nucleotides [D13.695]
- Polynucleotides [D13.695.578]
- Oligonucleotides [D13.695.578.424]
- Oligonucleotides, Antisense [D13.695.578.424.480]
- Oligodeoxyribonucleotides, Antisense [D13.695.578.424.480.640]
- Chemical Actions and Uses [D27]
- Specialty Uses of Chemicals [D27.720]
- Laboratory Chemicals [D27.720.470]
- Molecular Probes [D27.720.470.530]
- Nucleic Acid Probes [D27.720.470.530.600]
- Antisense Elements (Genetics) [D27.720.470.530.600.150]
- DNA, Antisense [D27.720.470.530.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.200.640]
- Oligonucleotides, Antisense [D27.720.470.530.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.640.640]
Below are MeSH descriptors whose meaning is more specific than "Oligodeoxyribonucleotides, Antisense".
This graph shows the total number of publications written about "Oligodeoxyribonucleotides, Antisense" by people in Harvard Catalyst Profiles by year, and whether "Oligodeoxyribonucleotides, Antisense" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 |
2000 | 1 | 2 | 3 |
2001 | 2 | 2 | 4 |
2002 | 1 | 1 | 2 |
2003 | 2 | 3 | 5 |
2004 | 1 | 1 | 2 |
2005 | 4 | 5 | 9 |
2007 | 1 | 0 | 1 |
2009 | 1 | 2 | 3 |
2010 | 0 | 5 | 5 |
2012 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2016 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
Below are the most recent publications written about "Oligodeoxyribonucleotides, Antisense" by people in Profiles.
-
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment. J Clin Invest. 2019 11 01; 129(11):4817-4831.
-
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin Amyloidosis. J Manag Care Spec Pharm. 2019 Jan; 25(1):10-15.
-
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest. 2018 08 01; 128(8):3558-3567.
-
Targeting noncoding RNAs in disease. J Clin Invest. 2017 Mar 01; 127(3):761-771.
-
Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World J Gastroenterol. 2016 Dec 07; 22(45):9954-9965.
-
Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. J Neurosci. 2015 Apr 15; 35(15):6038-50.
-
Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing. Mov Disord. 2014 Sep 15; 29(11):1455-61.
-
Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male rats. Am J Physiol Endocrinol Metab. 2014 Nov 01; 307(9):E773-83.
-
Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics. 2013 Jul; 10(3):486-97.
-
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013 May; 12(5):435-42.